Print this page    •   Back to Web version of article

International News
Ugandan Pharmaceutical Plant Wins WHO Approval for ARV Manufacturing

March 11, 2010

The WHO recently approved the manufacturing of antiretrovirals (ARVs) in Kampala, Uganda, by the pharmaceutical company Quality Chemicals Industries, New Vision/allAfrica.com reports. The plant is the first to win WHO approval outside of South Africa and is expected to "reduce the monthly cost of ARVs from sh30,000 to sh16,000 (29 to 14 USD)," according to the news service. The company "intends to export to neighbouring Kenya, Burundi, Rwanda, Tanzania, the Democratic Republic of Congo and Sudan," New Vision/allAfrica.com writes (Nabusoba, 3/10).

Back to other news for March 2010


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.



This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art55785.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.